|
1
|
Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection.
|
J Exp Med
|
2008
|
5.94
|
|
2
|
Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero.
|
Science
|
2008
|
5.76
|
|
3
|
Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens.
|
J Virol
|
2004
|
3.58
|
|
4
|
Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection.
|
Proc Natl Acad Sci U S A
|
2011
|
3.53
|
|
5
|
CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset.
|
Blood
|
2010
|
3.32
|
|
6
|
Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment.
|
J Virol
|
2005
|
3.07
|
|
7
|
Functionally distinct subsets of human NK cells and monocyte/DC-like cells identified by coexpression of CD56, CD7, and CD4.
|
Blood
|
2009
|
2.43
|
|
8
|
Optimization of methods to assess human mucosal T-cell responses to HIV infection.
|
J Immunol Methods
|
2003
|
2.32
|
|
9
|
Comparison of the ELISPOT and cytokine flow cytometry assays for the enumeration of antigen-specific T cells.
|
J Immunol Methods
|
2003
|
2.28
|
|
10
|
Tregs control the development of symptomatic West Nile virus infection in humans and mice.
|
J Clin Invest
|
2009
|
2.18
|
|
11
|
Cutting Edge: KIR3DS1, a gene implicated in resistance to progression to AIDS, encodes a DAP12-associated receptor expressed on NK cells that triggers NK cell activation.
|
J Immunol
|
2007
|
1.87
|
|
12
|
Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity.
|
Blood
|
2012
|
1.81
|
|
13
|
Regulation of T cell responses in the developing human fetus.
|
J Immunol
|
2006
|
1.78
|
|
14
|
Immunologic and virologic evolution during periods of intermittent and persistent low-level viremia.
|
AIDS
|
2004
|
1.75
|
|
15
|
Selective loss of innate CD4(+) V alpha 24 natural killer T cells in human immunodeficiency virus infection.
|
J Virol
|
2002
|
1.74
|
|
16
|
Strong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removal.
|
PLoS One
|
2006
|
1.73
|
|
17
|
Trafficking of human immunodeficiency virus type 1-specific CD8+ T cells to gut-associated lymphoid tissue during chronic infection.
|
J Virol
|
2003
|
1.71
|
|
18
|
T cell responses to human endogenous retroviruses in HIV-1 infection.
|
PLoS Pathog
|
2007
|
1.70
|
|
19
|
Seroreversion in subjects receiving antiretroviral therapy during acute/early HIV infection.
|
Clin Infect Dis
|
2006
|
1.65
|
|
20
|
Highly effective control of an AIDS virus challenge in macaques by using vesicular stomatitis virus and modified vaccinia virus Ankara vaccine vectors in a single-boost protocol.
|
J Virol
|
2004
|
1.58
|
|
21
|
Rapid progressing allele HLA-B35 Px restricted anti-HIV-1 CD8+ T cells recognize vestigial CTL epitopes.
|
PLoS One
|
2010
|
1.49
|
|
22
|
FOXP3 expressing CD127lo CD4+ T cells inversely correlate with CD38+ CD8+ T cell activation levels in primary HIV-1 infection.
|
J Leukoc Biol
|
2007
|
1.47
|
|
23
|
Conferral of enhanced natural killer cell function by KIR3DS1 in early human immunodeficiency virus type 1 infection.
|
J Virol
|
2008
|
1.47
|
|
24
|
Human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T(EMRA) cells in early infection are linked to control of HIV-1 viremia and predict the subsequent viral load set point.
|
J Virol
|
2007
|
1.46
|
|
25
|
Abundant expression of granzyme A, but not perforin, in granules of CD8+ T cells in GALT: implications for immune control of HIV-1 infection.
|
J Immunol
|
2004
|
1.46
|
|
26
|
Nine-color flow cytometry for accurate measurement of T cell subsets and cytokine responses. Part I: Panel design by an empiric approach.
|
Cytometry A
|
2008
|
1.40
|
|
27
|
CD56negCD16⁺ NK cells are activated mature NK cells with impaired effector function during HIV-1 infection.
|
Retrovirology
|
2013
|
1.30
|
|
28
|
Sequential broadening of CTL responses in early HIV-1 infection is associated with viral escape.
|
PLoS One
|
2007
|
1.30
|
|
29
|
Amplification of low-frequency antiviral CD8 T cell responses using autologous dendritic cells.
|
AIDS
|
2002
|
1.27
|
|
30
|
Natural killer cells in perinatally HIV-1-infected children exhibit less degranulation compared to HIV-1-exposed uninfected children and their expression of KIR2DL3, NKG2C, and NKp46 correlates with disease severity.
|
J Immunol
|
2007
|
1.25
|
|
31
|
Broadly immunogenic HLA class I supertype-restricted elite CTL epitopes recognized in a diverse population infected with different HIV-1 subtypes.
|
J Immunol
|
2008
|
1.25
|
|
32
|
HIV-specific CD8+ T cell function in children with vertically acquired HIV-1 infection is critically influenced by age and the state of the CD4+ T cell compartment.
|
J Immunol
|
2003
|
1.25
|
|
33
|
Expression profile of host restriction factors in HIV-1 elite controllers.
|
Retrovirology
|
2013
|
1.24
|
|
34
|
T cell immunity in acute HIV-1 infection.
|
J Infect Dis
|
2010
|
1.22
|
|
35
|
Development of innate CD4+ alpha-chain variable gene segment 24 (Valpha24) natural killer T cells in the early human fetal thymus is regulated by IL-7.
|
Proc Natl Acad Sci U S A
|
2004
|
1.21
|
|
36
|
Dual pressure from antiretroviral therapy and cell-mediated immune response on the human immunodeficiency virus type 1 protease gene.
|
J Virol
|
2003
|
1.19
|
|
37
|
Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infection.
|
J Virol
|
2011
|
1.19
|
|
38
|
Suppression of HIV-1 plasma viral load below detection preserves IL-17 producing T cells in HIV-1 infection.
|
AIDS
|
2008
|
1.14
|
|
39
|
Increased adhesion molecule and chemokine receptor expression on CD8+ T cells trafficking to cerebrospinal fluid in HIV-1 infection.
|
J Infect Dis
|
2004
|
1.14
|
|
40
|
HERV-K-specific T cells eliminate diverse HIV-1/2 and SIV primary isolates.
|
J Clin Invest
|
2012
|
1.14
|
|
41
|
Dominant effector memory characteristics, capacity for dynamic adaptive expansion, and sex bias in the innate Valpha24 NKT cell compartment.
|
Eur J Immunol
|
2003
|
1.13
|
|
42
|
Enhanced ELISPOT detection of antigen-specific T cell responses from cryopreserved specimens with addition of both IL-7 and IL-15--the Amplispot assay.
|
J Immunol Methods
|
2002
|
1.13
|
|
43
|
Nucleoside analogue reverse transcriptase inhibitors differentially inhibit human LINE-1 retrotransposition.
|
PLoS One
|
2008
|
1.11
|
|
44
|
Psoriasis patients are enriched for genetic variants that protect against HIV-1 disease.
|
PLoS Genet
|
2012
|
1.10
|
|
45
|
Increased expression of intrinsic antiviral genes in HLA-B*57-positive individuals.
|
J Leukoc Biol
|
2013
|
1.09
|
|
46
|
Inhibition of antigen-specific T cell proliferation and cytokine production by protein kinase A type I.
|
J Immunol
|
2002
|
1.08
|
|
47
|
Effects of cellular activation on anti-HIV-1 restriction factor expression profile in primary cells.
|
J Virol
|
2013
|
1.05
|
|
48
|
CD7 is a differentiation marker that identifies multiple CD8 T cell effector subsets.
|
J Immunol
|
2003
|
1.03
|
|
49
|
Lower cytokine secretion ex vivo by natural killer T cells in HIV-infected individuals is associated with higher CD161 expression.
|
AIDS
|
2009
|
1.03
|
|
50
|
HIV-1/HSV-2 co-infected adults in early HIV-1 infection have elevated CD4+ T cell counts.
|
PLoS One
|
2007
|
1.03
|
|
51
|
Single-cell, phosphoepitope-specific analysis demonstrates cell type- and pathway-specific dysregulation of Jak/STAT and MAPK signaling associated with in vivo human immunodeficiency virus type 1 infection.
|
J Virol
|
2008
|
1.03
|
|
52
|
ELISPOT cell rescue.
|
J Immunol Methods
|
2004
|
1.02
|
|
53
|
Identification of human endogenous retrovirus-specific T cell responses in vertically HIV-1-infected subjects.
|
J Virol
|
2011
|
1.01
|
|
54
|
Vaccination with cancer- and HIV infection-associated endogenous retrotransposable elements is safe and immunogenic.
|
J Immunol
|
2012
|
1.01
|
|
55
|
Generation of CD3+CD8low thymocytes in the HIV type 1-infected thymus.
|
J Immunol
|
2002
|
1.00
|
|
56
|
Individuals with pulmonary tuberculosis have lower levels of circulating CD1d-restricted NKT cells.
|
J Infect Dis
|
2007
|
1.00
|
|
57
|
A comprehensive ex vivo functional analysis of human NKT cells reveals production of MIP1-α and MIP1-β, a lack of IL-17, and a Th1-bias in males.
|
PLoS One
|
2010
|
1.00
|
|
58
|
IL-2 production correlates with effector cell differentiation in HIV-specific CD8+ T cells.
|
AIDS Res Ther
|
2006
|
0.99
|
|
59
|
Detection of T lymphocytes specific for human endogenous retrovirus K (HERV-K) in patients with seminoma.
|
AIDS Res Hum Retroviruses
|
2006
|
0.99
|
|
60
|
Expansion of CD1d-restricted NKT cells in patients with primary HIV-1 infection treated with interleukin-2.
|
Blood
|
2005
|
0.98
|
|
61
|
R5 human immunodeficiency virus type 1 (HIV-1) replicates more efficiently in primary CD4+ T-cell cultures than X4 HIV-1.
|
J Virol
|
2004
|
0.98
|
|
62
|
Human endogenous retrovirus K106 (HERV-K106) was infectious after the emergence of anatomically modern humans.
|
PLoS One
|
2011
|
0.97
|
|
63
|
Residual viral replication during antiretroviral therapy boosts human immunodeficiency virus type 1-specific CD8+ T-cell responses in subjects treated early after infection.
|
J Virol
|
2002
|
0.97
|
|
64
|
Elevated frequency of gamma interferon-producing NK cells in healthy adults vaccinated against influenza virus.
|
Clin Vaccine Immunol
|
2007
|
0.97
|
|
65
|
Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposure.
|
J Infect Dis
|
2002
|
0.96
|
|
66
|
Emergence of drug-resistant HIV-1 variants in patients undergoing structured treatment interruptions.
|
AIDS
|
2002
|
0.96
|
|
67
|
Relevance of HIV-1-specific CD4+ helper T-cell responses during structured treatment interruptions in patients with CD4+ T-cell nadir above 400/mm3.
|
J Acquir Immune Defic Syndr
|
2004
|
0.95
|
|
68
|
Immunity to HIV-1 is influenced by continued natural exposure to exogenous virus.
|
PLoS Pathog
|
2008
|
0.95
|
|
69
|
Immune reconstitution of CD56(dim) NK cells in individuals with primary HIV-1 infection treated with interleukin-2.
|
J Infect Dis
|
2008
|
0.94
|
|
70
|
Nine-color flow cytometry for accurate measurement of T cell subsets and cytokine responses. Part II: Panel performance across different instrument platforms.
|
Cytometry A
|
2008
|
0.94
|
|
71
|
Higher frequency of HIV-1-specific T cell immune responses in African American children vertically infected with HIV-1.
|
J Infect Dis
|
2005
|
0.94
|
|
72
|
Differentiation and functional regulation of human fetal NK cells.
|
J Clin Invest
|
2013
|
0.94
|
|
73
|
The frequency of CD127low expressing CD4+CD25high T regulatory cells is inversely correlated with human T lymphotrophic virus type-1 (HTLV-1) proviral load in HTLV-1-infection and HTLV-1-associated myelopathy/tropical spastic paraparesis.
|
BMC Immunol
|
2008
|
0.93
|
|
74
|
Transcriptional errors in human immunodeficiency virus type 1 generate targets for T-cell responses.
|
Clin Vaccine Immunol
|
2009
|
0.92
|
|
75
|
HIV-1-specific CD4+ T cell responses in chronically HIV-1 infected blippers on antiretroviral therapy in relation to viral replication following treatment interruption.
|
J Clin Immunol
|
2006
|
0.92
|
|
76
|
A decreased frequency of regulatory T cells in patients with common variable immunodeficiency.
|
PLoS One
|
2009
|
0.91
|
|
77
|
Expansion of CD8+ T cells lacking Sema4D/CD100 during HIV-1 infection identifies a subset of T cells with decreased functional capacity.
|
Blood
|
2011
|
0.91
|
|
78
|
Changes in CD4+ T-cell differentiation phenotype during structured treatment interruption in patients with chronic HIV-1 infection.
|
J Acquir Immune Defic Syndr
|
2003
|
0.91
|
|
79
|
Skewed distribution of circulating activated natural killer T (NKT) cells in patients with common variable immunodeficiency disorders (CVID).
|
PLoS One
|
2010
|
0.90
|
|
80
|
Partial treatment interruption of protease inhibitors augments HIV-specific immune responses in vertically infected pediatric patients.
|
AIDS
|
2005
|
0.90
|
|
81
|
Cross-sectional dating of novel haplotypes of HERV-K 113 and HERV-K 115 indicate these proviruses originated in Africa before Homo sapiens.
|
Mol Biol Evol
|
2009
|
0.90
|
|
82
|
IL-2 immunotherapy to recently HIV-1 infected adults maintains the numbers of IL-17 expressing CD4+ T (T(H)17) cells in the periphery.
|
J Clin Immunol
|
2010
|
0.89
|
|
83
|
Poorly soluble peptides can mimic authentic ELISPOT responses.
|
J Immunol Methods
|
2004
|
0.89
|
|
84
|
A novel human CD4+ T-cell inducer subset with potent immunostimulatory properties.
|
Eur J Immunol
|
2010
|
0.89
|
|
85
|
The calm mouse: an animal model of stress reduction.
|
Mol Med
|
2012
|
0.89
|
|
86
|
Dendritic cell amplification of HIV type 1-specific CD8+ T cell responses in exposed, seronegative heterosexual women.
|
AIDS Res Hum Retroviruses
|
2002
|
0.88
|
|
87
|
Tenofovir treatment augments anti-viral immunity against drug-resistant SIV challenge in chronically infected rhesus macaques.
|
Retrovirology
|
2006
|
0.88
|
|
88
|
Presence of human immunodeficiency virus-1-specific CD4 and CD8 cellular immune responses in children with full or partial virus suppression.
|
J Infect Dis
|
2003
|
0.87
|
|
89
|
Expansion of CD7(low) and CD7(negative) CD8 T-cell effector subsets in HIV-1 infection: correlation with antigenic load and reversion by antiretroviral treatment.
|
Blood
|
2004
|
0.87
|
|
90
|
Increased number and function of natural killer cells in human immunodeficiency virus 1-positive subjects co-infected with herpes simplex virus 2.
|
Immunology
|
2009
|
0.86
|
|
91
|
HTLV-1 tax specific CD8+ T cells express low levels of Tim-3 in HTLV-1 infection: implications for progression to neurological complications.
|
PLoS Negl Trop Dis
|
2011
|
0.86
|
|
92
|
Skewed distribution of natural killer cells in psoriasis skin lesions.
|
Exp Dermatol
|
2013
|
0.85
|
|
93
|
Variability of HIV-1 genomes among children and adolescents from São Paulo, Brazil.
|
PLoS One
|
2013
|
0.85
|
|
94
|
Human endogenous retrovirus K(HML-2) Gag- and Env-specific T-cell responses are infrequently detected in HIV-1-infected subjects using standard peptide matrix-based screening.
|
Clin Vaccine Immunol
|
2011
|
0.84
|
|
95
|
Influence of HAART on alternative reading frame immune responses over the course of HIV-1 infection.
|
PLoS One
|
2012
|
0.84
|
|
96
|
HIV-1 Vpu interference with innate cell-mediated immune mechanisms.
|
Curr HIV Res
|
2012
|
0.84
|
|
97
|
CD8 T cell effector maturation in HIV-1-infected children.
|
Virology
|
2006
|
0.84
|
|
98
|
Interleukin-10-secreting T cells define a suppressive subset within the HIV-1-specific T-cell population.
|
Eur J Immunol
|
2009
|
0.83
|
|
99
|
Evaluation of CD8+ T-cell and antibody responses following transient increased viraemia in rhesus macaques infected with live, attenuated simian immunodeficiency virus.
|
J Gen Virol
|
2005
|
0.83
|
|
100
|
Human endogenous retrovirus expression is inversely associated with chronic immune activation in HIV-1 infection.
|
PLoS One
|
2012
|
0.83
|
|
101
|
Immunodominance of HIV-1 specific CD8+ T-cell responses is related to disease progression rate in vertically infected adolescents.
|
PLoS One
|
2011
|
0.83
|
|
102
|
LINE-1 retrotransposable element DNA accumulates in HIV-1-infected cells.
|
J Virol
|
2013
|
0.83
|
|
103
|
Herpes simplex virus and HIV-1: deciphering viral synergy.
|
Lancet Infect Dis
|
2009
|
0.82
|
|
104
|
Expansion in CD39⁺ CD4⁺ immunoregulatory t cells and rarity of Th17 cells in HTLV-1 infected patients is associated with neurological complications.
|
PLoS Negl Trop Dis
|
2013
|
0.82
|
|
105
|
Boosting of SIV-specific T cell responses in rhesus macaques that resist repeated intravaginal challenge with SIVmac251.
|
AIDS Res Hum Retroviruses
|
2002
|
0.82
|
|
106
|
Age-related expansion of Tim-3 expressing T cells in vertically HIV-1 infected children.
|
PLoS One
|
2012
|
0.81
|
|
107
|
Immune escape mutations detected within HIV-1 epitopes associated with viral control during treatment interruption.
|
J Acquir Immune Defic Syndr
|
2010
|
0.81
|
|
108
|
Protective effect of human endogenous retrovirus K dUTPase variants on psoriasis susceptibility.
|
J Invest Dermatol
|
2012
|
0.81
|
|
109
|
Targeting of conserved gag-epitopes in early HIV infection is associated with lower plasma viral load and slower CD4(+) T cell depletion.
|
AIDS Res Hum Retroviruses
|
2013
|
0.80
|
|
110
|
Lower numbers of natural killer T cells in HIV-1 and Mycobacterium leprae co-infected patients.
|
Immunology
|
2012
|
0.80
|
|
111
|
Invariant natural killer T (iNKT) cell exhaustion in sarcoidosis.
|
Eur J Immunol
|
2013
|
0.80
|
|
112
|
Associations between antibodies to a panel of Plasmodium falciparum specific antigens and response to sub-optimal antimalarial therapy in Kampala, Uganda.
|
PLoS One
|
2012
|
0.80
|
|
113
|
Human endogenous retrovirus K(HML-2) Gag and Env specific T-cell responses are not detected in HTLV-I-infected subjects using standard peptide screening methods.
|
J Negat Results Biomed
|
2013
|
0.79
|
|
114
|
HIV-1-specific T Cell-dependent natural killer (NK) cell activation: major contribution by NK cells to interferon-gamma production in response to HIV-1 antigens.
|
AIDS Res Hum Retroviruses
|
2009
|
0.78
|
|
115
|
T cells target APOBEC3 proteins in human immunodeficiency virus type 1-infected humans and simian immunodeficiency virus-infected Indian rhesus macaques.
|
J Virol
|
2013
|
0.78
|
|
116
|
T lymphocyte responses against human parvovirus B19: small virus, big response.
|
Pathol Biol (Paris)
|
2002
|
0.78
|
|
117
|
Treatment interruption in chronic HIV-1 infection: does it deliver?
|
Curr Opin HIV AIDS
|
2007
|
0.78
|
|
118
|
Multidrug-resistant, dual-tropic HIV-1 and rapid progression.
|
Lancet
|
2005
|
0.77
|
|
119
|
Association of differentiation state of CD4+ T cells and disease progression in HIV-1 perinatally infected children.
|
PLoS One
|
2012
|
0.77
|
|
120
|
Decay kinetics of HIV-1 specific T cell responses in vertically HIV-1 exposed seronegative infants.
|
Front Immunol
|
2012
|
0.77
|
|
121
|
Correction: Rapid Progressing Allele HLA-B35 Px Restricted Anti-HIV-1 CD8+ T Cells Recognize Vestigial CTL Epitopes.
|
PLoS One
|
2016
|
0.75
|
|
122
|
CD57 expression and cytokine production by T cells in lesional and unaffected skin from patients with psoriasis.
|
PLoS One
|
2013
|
0.75
|
|
123
|
Diminished humoral responses against and reduced gene expression levels of human endogenous retrovirus-K (HERV-K) in psoriasis.
|
J Transl Med
|
2014
|
0.75
|
|
124
|
Correction: p16INK4a Expression and Immunologic Aging in Chronic HIV Infection.
|
PLoS One
|
2017
|
0.75
|
|
125
|
Inversion of the Vδ1 to Vδ2 γδ T cell ratio in CVID is not restored by IVIg and is associated with immune activation and exhaustion.
|
Medicine (Baltimore)
|
2016
|
0.75
|
|
126
|
Brief Report: HIV-1 gp120 T-Cell Responses Correspond to Infection Outcomes in the Global iPrEx Chemoprophylaxis Trial.
|
J Acquir Immune Defic Syndr
|
2016
|
0.75
|
|
127
|
Differential expression of CD96 surface molecule represents CD8⁺ T cells with dissimilar effector function during HIV-1 infection.
|
PLoS One
|
2012
|
0.75
|
|
128
|
Human T-lymphotropic virus 1, breastfeeding, and antiretroviral therapy.
|
AIDS Res Hum Retroviruses
|
2014
|
0.75
|
|
129
|
Examining HIV Viral Load in a Matched Cohort of HIV Positive Individuals With and Without Psoriasis.
|
J Drugs Dermatol
|
2017
|
0.75
|
|
130
|
A plea for justice for jailed medical workers.
|
Science
|
2006
|
0.75
|